Genomic Mining Limited - Period Ending 2015-03-31

Registration number: NI039951

Genomic Mining Limited

Annual Report and Unaudited Accounts

for the Year Ended 31 March 2015
 

Duffy & Co (A & T) Ltd
Chartered Accountants
126 Eglantine Avenue
Belfast
Co Antrim
BT9 6EU

Genomic Mining Limited
(Registration number: NI039951)
Balance Sheet at 31 March 2015

		Note			2015 £			2014 £
Current assets
Debtors		2			4			4
Cash at bank and in hand					380			380
					384			384
Creditors: Amounts falling due within one year		3			(15,774)			(15,774)
Net liabilities					(15,390)			(15,390)
Capital and reserves
Called up share capital		4			50,504			50,504
Profit and loss account					(65,894)			(65,894)
Shareholders' deficit					(15,390)			(15,390)

For the year ending 31 March 2015 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the Financial Reporting Standard for Smaller Entities (effective 2008).

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Approved and authorised for issue by the Board on 27 April 2015 and signed on its behalf by:

.........................................
Dr Paul Harkin
Director

The notes on page 2 form an integral part of these financial statements.
Page 1

Genomic Mining Limited
Notes to the financial statements for the Year Ended 31 March 2015
......... continued

1	Accounting policies

Trading status

The company was dormant and has not traded during the year.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability in the balance sheet. The corresponding dividends relating to the liability component are charged as interest expense in the profit and loss account.

2

Debtors

		2015 £			2014 £
Other debtors		4			4

3	Creditors: Amounts falling due within one year

		2015 £			2014 £
Trade creditors		4,854			4,854
Other creditors		10,920			10,920
		15,774			15,774

4	Share capital

Allotted, called up and fully paid shares

	2015						2014
		No.			£			No.			£
A Ordinary of £0.10 each		200,040			20,004			200,040			20,004
B Ordinary of £0.10 each		190,000			19,000			190,000			19,000
A Convertible cumulative redeemable preference of £1 each		11,500			11,500			11,500			11,500
		401,540			50,504			401,540			50,504

Page 2